ArticleMolecular therapy : the journal of the American Society of Gene Therapy2018

Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.

Min Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.